p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 6, 2008, Pages 1085-1094

  Solé, Montse ^a   Hernandez Guillamon, Mar ^a   Boada, Mercè ^b,c   Unzeta, Mercedes ^a  

^a Facultat de Medicina   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Institut Catala de Neurociencies Aplicades   (Spain)

Author keywords

Apoptosis; Methylamine; p53; Semicarbazide sensitive amine oxidase; Smooth muscle cells; Transmembrane protein

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); EFFECTOR CASPASE; METHYLAMINE; PROTEIN BCL 2; PROTEIN P53; PUMA ALPHA PROTEIN; PUMA PROTEIN; VASCULAR ADHESION PROTEIN 1;

ANIMAL CELL; ARTICLE; BLOOD VESSEL; CATALYSIS; CELL DEATH; CELL THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RAT; TIME;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; AORTA, THORACIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL MEMBRANE; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; METHYLAMINES; MITOCHONDRIA; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 43549095196     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.02.014     Document Type: Article

References (84)

1. Lewinsohn R. Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues. Braz. J. Med. Biol. Res. 17 (1984) 223-256
2. Precious E., and Lyles G.A. Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery. J. Pharm. Pharmacol. 40 (1988) 627-633
3. Andres N., Lizcano J.M., Rodriguez M.J., Romera M., Unzeta M., and Mahy N. Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. J. Histochem. Cytochem. 49 (2001) 209-217
4. Jaakkola K., Kaunismaki K., Tohka S., Yegutkin G., Vanttinen E., Havia T., Pelliniemi L.J., Virolainen M., Jalkanen S., and Salmi M. Human vascular adhesion protein-1 in smooth muscle cells. Am. J. Pathol. 155 (1999) 1953-1965
5. Salmi M., and Jalkanen S. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. Eur. J. Immunol. 25 (1995) 2803-2812
6. Morris N.J., Ducret A., Aebersold R., Ross S.A., Keller S.R., and Lienhard G.E. Membrane amine oxidase cloning and identification as a major protein in the adipocyte plasma membrane. J. Biol. Chem. 272 (1997) 9388-9392
7. Lyles G.A. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects. Int. J. Biochem. Cell Biol. 28 (1996) 259-274
8. Gokturk C., Nilsson J., Nordquist J., Kristensson M., Svensson K., Soderberg C., Israelson M., Garpenstrand H., Sjoquist M., Oreland L., and Forsberg-Nilsson K. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am. J. Pathol. 163 (2003) 1921-1928
9. Stolen C.M., Yegutkin G.G., Kurkijarvi R., Bono P., Alitalo K., and Jalkanen S. Origins of serum semicarbazide-sensitive amine oxidase. Circ. Res. 95 (2004) 50-57
10. Abella A., Garcia-Vicente S., Viguerie N., Ros-Baro A., Camps M., Palacin M., Zorzano A., and Marti L. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47 (2004) 429-438
11. O'Sullivan J., Unzeta M., Healy J., O'Sullivan M.I., Davey G., and Tipton K.F. Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 25 (2004) 303-315
12. Enrique-Tarancon G., Marti L., Morin N., Lizcano J.M., Unzeta M., Sevilla L., Camps M., Palacin M., Testar X., Carpene C., and Zorzano A. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J. Biol. Chem. 273 (1998) 8025-8032
13. El Hadri K., Moldes M., Mercier N., Andreani M., Pairault J., and Feve B. Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 89-94
14. Salmi M., and Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257 (1992) 1407-1409
15. Salmi M., and Jalkanen S. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J. Exp. Med. 183 (1996) 569-579
16. Smith D.J., Salmi M., Bono P., Hellman J., Leu T., and Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188 (1998) 17-27
17. Precious E., Gunn C.E., and Lyles G.A. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem. Pharmacol. 37 (1988) 707-713
18. Dar M.S., Morselli P.L., and Bowman E.R. The enzymatic systems involved in the mammalian metabolism of methylamine. Gen. Pharmacol. 16 (1985) 557-560
19. Yu P.H., Lai C.T., and Zuo D.M. Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem. Res. 22 (1997) 615-620
20. Yu P.H., Wright S., Fan E.H., Lun Z.R., and Gubisne-Harberle D. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim. Biophys. Acta 1647 (2003) 193-199
21. Tyihak E., Bocsi J., Timar F., Racz G., and Szende B. Formaldehyde promotes and inhibits the proliferation of cultured tumour and endothelial cells. Cell Prolif. 34 (2001) 135-141
22. Yu P.H., and Zuo D.M. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 42 (1993) 594-603
23. Yu P.H. Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J. Neural Transm., Suppl. 52 (1998) 201-216
24. Heck H.D., Casanova M., and Starr T.B. Formaldehyde toxicity-new understanding. Crit. Rev. Toxicol. 20 (1990) 397-426
25. Gronvall J.L., Garpenstrand H., Oreland L., and Ekblom J. An autoradiographic method of visualising semicarbazide-sensitive amine oxidase activity in mouse tissue sections. Neurobiology (Bp) 8 (2000) 167-177
26. Yu P.H., and Zuo D.M. Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atherosclerosis 120 (1996) 189-197
27. Hernandez M., Sole M., Boada M., and Unzeta M. Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells. Biochim. Biophys. Acta 1763 (2006) 164-173
28. Ferrer I., Lizcano J.M., Hernandez M., and Unzeta M. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurosci. Lett. 321 (2002) 21-24
29. del Mar Hernandez M., Esteban M., Szabo P., Boada M., and Unzeta M. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. Neurosci. Lett. 384 (2005) 183-187
30. Sole M., Hernandez M., Boada M., and Unzeta M. Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). J. Neural Transm. 114 (2007) 763-767
31. Plumb J.A., Milroy R., and Kaye S.B. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 49 (1989) 4435-4440
32. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
33. Morishima N., Nakanishi K., Takenouchi H., Shibata T., and Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 277 (2002) 34287-34294
34. Rao R.V., Castro-Obregon S., Frankowski H., Schuler M., Stoka V., del Rio G., Bredesen D.E., and Ellerby H.M. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J. Biol. Chem. 277 (2002) 21836-21842
35. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13 (1999) 1211-1233
36. Cho S.G., and Choi E.J. Apoptotic signaling pathways: caspases and stress-activated protein kinases. J. Biochem. Mol. Biol. 35 (2002) 24-27
37. Jin Z., and El Deiry W.S. Overview of cell death signaling pathways. Cancer Biol. Ther. 4 (2005) 139-163
38. Reed J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol. 7 (1995) 541-546
39. Chipuk J.E., and Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ. 13 (2006) 994-1002
40. Unger T., Sionov R.V., Moallem E., Yee C.L., Howley P.M., Oren M., and Haupt Y. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18 (1999) 3205-3212
41. Nakano K., and Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7 (2001) 683-694
42. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K.H., Han J., Chittenden T., Ihle J.N., McKinnon P.J., Cleveland J.L., and Zambetti G.P. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4 (2003) 321-328
43. Chipuk J.E., Bouchier-Hayes L., Kuwana T., Newmeyer D.D., and Green D.R. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309 (2005) 1732-1735
44. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., and Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285 (1999) 1733-1737
45. Boomsma F., Derkx F.H., van den Meiracker A.H., Man in 't Veld A.J., and Schalekamp M.A. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin. Sci. (Lond) 88 (1995) 675-679
46. Garpenstrand H., Ekblom J., Backlund L.B., Oreland L., and Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet. Med. 16 (1999) 514-521
47. Boomsma F., van Veldhuisen D.J., de Kam P.J., Man in't Veld A.J., Mosterd A., Lie K.I., and Schalekamp M.A. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc. Res. 33 (1997) 387-391
48. Weiss H.G., Klocker J., Labeck B., Nehoda H., Aigner F., Klingler A., Ebenbichler C., Foger B., Lechleitner M., Patsch J.R., and Schwelberger H.G. Plasma amine oxidase: a postulated cardiovascular risk factor in nondiabetic obese patients. Metabolism 52 (2003) 688-692
49. Kurkijarvi R., Yegutkin G.G., Gunson B.K., Jalkanen S., Salmi M., and Adams D.H. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 119 (2000) 1096-1103
50. Yu P.H. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. Med. Hypotheses 57 (2001) 175-179
51. Airas L., Mikkola J., Vainio J.M., Elovaara I., and Smith D.J. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. J. Neuroimmunol. 177 (2006) 132-135
52. Nagaraj R.H., Shipanova I.N., and Faust F.M. Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J. Biol. Chem. 271 (1996) 19338-19345
53. Gubisne-Haberle D., Hill W., Kazachkov M., Richardson J.S., and Yu P.H. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J. Pharmacol. Exp. Ther. 310 (2004) 1125-1132
54. Yu P.H., and Zuo D.M. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia 40 (1997) 1243-1250
55. Mathys K.C., Ponnampalam S.N., Padival S., and Nagaraj R.H. Semicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methylglyoxal-AGE: implications for vascular complications in diabetes. Biochem. Biophys. Res. Commun. 297 (2002) 863-869
56. Lichszteld K., and Kruk L. Singlet molecular oxygen in formaldehyde oxidation. Z. Phys. Chem. (N. F.) 108 (1979) 167-172
57. Ramos K., Grossman S.L., and Cox L.R. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. Toxicol. Appl. Pharmacol. 95 (1988) 61-71
58. Conklin D.J., Langford S.D., and Boor P.J. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Toxicol. Sci. 46 (1998) 386-392
59. Hysmith R.M., and Boor P.J. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells. Toxicology 51 (1988) 133-145
60. Baba S., Watanabe Y., Gejyo F., and Arakawa M. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin. Chim. Acta 136 (1984) 49-56
61. Stolen C.M., Madanat R., Marti L., Kari S., Yegutkin G.G., Sariola H., Zorzano A., and Jalkanen S. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. FASEB J. 18 (2004) 702-704
62. Gokturk C., Garpenstrand H., Nilsson J., Nordquist J., Oreland L., and Forsberg-Nilsson K. Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice. Biochim. Biophys. Acta 1647 (2003) 88-91
63. Wood P.L., Khan M.A., and Moskal J.R. The concept of "aldehyde load" in neurodegenerative mechanisms: cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3-acetamidopropanal and 4-aminobutanal in a retinal ganglion cell line. Brain Res. 1145 (2007) 150-156
64. Niwa K., Inanami O., Yamamori T., Ohta T., Hamasu T., and Kuwabara M. Redox regulation of PI3K/Akt and p53 in bovine aortic endothelial cells exposed to hydrogen peroxide. Antioxid. Redox Signal. 5 (2003) 713-722
65. Teng S., Beard K., Pourahmad J., Moridani M., Easson E., Poon R., and O'Brien P.J. The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chem. Biol. Interact. 130-132 (2001) 285-296
66. Katiyar S.K., Roy A.M., and Baliga M.S. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol. Cancer Ther. 4 (2005) 207-216
67. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
68. Chipuk J.E., Maurer U., Green D.R., and Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4 (2003) 371-381
69. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., and Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303 (2004) 1010-1014
70. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
71. Rao R.V., Peel A., Logvinova A., del Rio G., Hermel E., Yokota T., Goldsmith P.C., Ellerby L.M., Ellerby H.M., and Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 514 (2002) 122-128
72. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
73. Haupt S., Berger M., Goldberg Z., and Haupt Y. Apoptosis - the p53 network. J. Cell Sci. 116 (2003) 4077-4085
74. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., and Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288 (2000) 1053-1058
75. Sax J.K., Fei P., Murphy M.E., Bernhard E., Korsmeyer S.J., and El Deiry W.S. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 4 (2002) 842-849
76. Caelles C., Helmberg A., and Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370 (1994) 220-223
77. Jiang M., Wei Q., Wang J., Du Q., Yu J., Zhang L., and Dong Z. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25 (2006) 4056-4066
78. Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., and Newmeyer D.D. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 17 (2005) 525-535
79. Ming L., Wang P., Bank A., Yu J., and Zhang L. PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J. Biol. Chem. 281 (2006) 16034-16042
80. Lakkaraju A., Dubinsky J.M., Low W.C., and Rahman Y.E. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes. J. Biol. Chem. 276 (2001) 32000-32007
81. Alves da Costa C., Paitel E., Mattson M.P., Amson R., Telerman A., Ancolio K., and Checler F. Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4043-4048
82. Ucar G., Topaloglu E., Burak K.H., and Gumusel B. Elevated semicarbazide-sensitive amine oxidase (SSAO) activity in lung with ischemia-reperfusion injury: protective effect of ischemic preconditioning plus SSAO inhibition. Life Sci. 78 (2005) 421-427
83. Wang E.Y., Gao H., Salter-Cid L., Zhang J., Huang L., Podar E.M., Miller A., Zhao J., O'rourke A., and Linnik M.D. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. J. Med. Chem. 49 (2006) 2166-2173
84. O'Rourke A.M., Wang E.Y., Salter-Cid L., Huang L., Miller A., Podar E., Gao H.F., Jones D.S., and Linnik M.D. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J. Neural Transm. 114 (2007) 845-849